Join us at PEGS Europe Virtual on November 9-12! Our CEO, Jens Frauenfeld, will be discussing drug development against challenging targets including GPCRs and Ion Channels using the Salipro® Technology platform on November 12 at 4pm CET.
Salipro Biotech presents at PEGS Europe Virtual
Previous
Previous
Salipro Biotech presents at Antibody Engineering & Therapeutics Virtual
Next
Next